Biotech Firm's Shares Plummet Amid Planned Pivot to Dogecoin Mining
Dogecoin mining is quite the shift for biotech firm Coeptis Therapeutics, and shareholders don't appear thrilled with the proposed move.
Original source
Read on DecryptRelated market context
Bitcoin faces one of its biggest mining difficulty drops as miner margins collapse
The Bitcoin network is poised to execute one of the largest downward adjustments to its mining difficulty in its 17-year history t...
Uranium Holds Above $85 as Mining ETF Rebounds From June Sell-Off
The latest charts display that the market is divided into stable physical prices and uranium shares trying to regain momentum afte...
Bitcoin Mining Cost Model Points To $47,000 Floor, But Analysts Urge Caution
TL;DR Crypto Rover says Bitcoin has never bottomed below electrical production cost, currently estimated at $47,000. Mining-cost m...
SpaceX shares surge 19% in debut after blockbuster IPO, sending shockwaves through crypto markets
SpaceX's IPO success highlights a shift in investment focus, potentially diverting capital from crypto markets and impacting digit...
US-Iran deal nearly finalized as mediators report progress, Bitcoin responds to geopolitical shifts
The US-Iran deal's progress could stabilize geopolitical tensions, impacting global oil markets and influencing cryptocurrency vol...
Crypto Today: Bitcoin Mining Heat, Regulatory Push, and ETF Rumours Shape Market
Bitcoin mining heats Canadian homes, Coinbase pushes regulation, ETF rumours lift prices, and DeFi volume surges 1,000%. The post...